Cargando…
MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST
MicroRNA (miRNA) and long non-coding RNA (lncRNA) have been demonstrated to participate in the progression of many cancers. Hepatocellular carcinoma (HCC) is one of the most common and aggressive malignant tumors worldwide, while the molecular mechanisms underlying HCC tumorigenesis are not complete...
Autores principales: | Zhuang, L K, Yang, Y T, Ma, X, Han, B, Wang, Z S, Zhao, Q Y, Wu, L Q, Qu, Z Q |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855645/ https://www.ncbi.nlm.nih.gov/pubmed/27100897 http://dx.doi.org/10.1038/cddis.2016.100 |
Ejemplares similares
-
MicroRNA-92a Inhibition Attenuates Hypoxia/Reoxygenation-Induced Myocardiocyte Apoptosis by Targeting Smad7
por: Zhang, Busheng, et al.
Publicado: (2014) -
MicroRNA-155 facilitates skeletal muscle regeneration by balancing pro- and anti-inflammatory macrophages
por: Nie, M, et al.
Publicado: (2016) -
microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer
por: Ueno, K, et al.
Publicado: (2013) -
[Corrigendum] MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7
por: Yang, Wei, et al.
Publicado: (2023) -
MicroRNA-455 suppresses the oncogenic function of HDAC2 in human colorectal cancer
por: Mao, Q.D., et al.
Publicado: (2017)